Trial
NCT00282399
A Clinical Trial of Decitabine in Patients With Myelodysplastic Syndrome
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Eisai Inc.
Collaborators
—
Condition
Myelodysplastic Syndrome
Intervention
Subcutaneous Decitabine
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-10-28